The senior management of Jiangsu Kanion Pharmaceutical (600557.SH) plans to collectively increase their holdings in the company by no less than 120,000 shares.

Jiangsu Kanion Pharmaceutical (600557.SH) announced that Mr. Yang Yongchun, Director and General Manager of the company, Mr. Gao Haixin, Director, Mr. Chen Xuebin, Director, Mr. Liu Quan, Deputy General Manager, Mr. Wang Chuanlei, Deputy General Manager, and Mr. Pan Yu, Deputy General Manager, plan to increase their holdings of the company's shares by a total of no less than 120,000 shares within one month from the date of the announcement through the Shanghai Stock Exchange trading system in a centralized bidding manner, based on their confidence in the company's future development and long-term investment value.